These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9831423)

  • 1. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features.
    Roozendaal C; Van Milligen de Wit AW; Haagsma EB; Horst G; Schwarze C; Peter HH; Kleibeuker JH; Tervaert JW; Limburg PC; Kallenberg CG
    Am J Med; 1998 Nov; 105(5):393-9. PubMed ID: 9831423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
    Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
    J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis.
    Dobric S; Popovic D; Nikolic M; Andrejevic S; Spuran M; Bonaci-Nikolic B
    Clin Chem Lab Med; 2011 Nov; 50(3):503-9. PubMed ID: 22107137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
    Halbwachs-Mecarelli L; Nusbaum P; Noël LH; Reumaux D; Erlinger S; Grünfeld JP; Lesavre P
    Clin Exp Immunol; 1992 Oct; 90(1):79-84. PubMed ID: 1327593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases.
    Roozendaal C; de Jong MA; van den Berg AP; van Wijk RT; Limburg PC; Kallenberg CG
    J Hepatol; 2000 May; 32(5):734-41. PubMed ID: 10845659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
    Xin G; Zhao MH; Wang HY
    Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.
    Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH
    Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study.
    Ooi CJ; Lim BL; Cheong WK; Ling AE; Ng HS
    Ann Acad Med Singap; 2000 Nov; 29(6):704-7. PubMed ID: 11269973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis.
    Bansi DS; Lo S; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):111-6. PubMed ID: 8723413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis.
    Roozendaal C; Horst G; Pogány K; van Milligen de Wit AW; Kleibeuker JH; Haagsma EB; Limburg PC; Kallenberg CG
    Adv Exp Med Biol; 1998; 443():313-9. PubMed ID: 9781375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antineutrophil cytoplasmic antibodies in chronic inflammatory bowel diseases].
    Schlenker T; Apenberg S; Raedsch R; Andrassy K; Plachky J; Kommerell B
    Dtsch Med Wochenschr; 1992 Sep; 117(39):1463-8. PubMed ID: 1396127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.
    Peen E; Almer S; Bodemar G; Rydén BO; Sjölin C; Tejle K; Skogh T
    Gut; 1993 Jan; 34(1):56-62. PubMed ID: 8432453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).
    Stinton LM; Bentow C; Mahler M; Norman GL; Eksteen B; Mason AL; Kaplan GG; Lindkvist B; Hirschfield GM; Milkiewicz P; Cheung A; Janssen HL; Fritzler MJ
    PLoS One; 2014; 9(11):e112877. PubMed ID: 25397578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases].
    Schnabel A; Csernok E; Schultz H; Stoffel M; Herzberg C; Carroll SF; Gross WL
    Med Klin (Munich); 1997 Jul; 92(7):389-93. PubMed ID: 9324622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic antibodies in Bulgarian patients with rheumatoid arthritis: characterization and clinical associations.
    Manolova I; Dantcheva M
    Rheumatol Int; 2005 Dec; 26(2):107-14. PubMed ID: 16341903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.
    Haagsma EB; Mulder AH; Gouw AS; Horst G; Meerman L; Slooff MJ; Kallenberg CG
    J Hepatol; 1993 Aug; 19(1):8-14. PubMed ID: 8301047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis.
    Khanna D; Aggarwal A; Bhakuni DS; Dayal R; Misra R
    J Rheumatol; 2003 Jun; 30(6):1248-52. PubMed ID: 12784398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis.
    Schwarze C; Terjung B; Lilienweiss P; Beuers U; Herzog V; Sauerbruch T; Spengler U
    Clin Exp Immunol; 2003 Aug; 133(2):283-9. PubMed ID: 12869036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.